Journal of the Korean Society of Food Science and Nutrition (한국식품영양과학회지)

The Korean Society of Food Science and Nutrition (한국식품영양과학회)
권호 표지
DOI QR코드

DOI QR Code

Effects of Zinc Plus Arachidonic Acid on Insulin Resistance in High Fructose-Fed Rats

Zinc와 Arachidonic Acid가 고 Fructose 식이로 유도된 인슐린 저항성에 미치는 영향

  • 최철수 (가천의과학대학교) ;
  • 김영욱 (마산 삼성병원) ;
  • 이효선 (부산대학교 의학전문대학원) ;
  • 윤태호 (부산대학교 의학전문대학원) ;
  • 조병만 (부산대학교 의학전문대학원) ;
  • 이수일 (부산대학교 의학전문대학원) ;
  • 김성수 (부산대학교 의학전문대학원) ;
  • 황인경 (부산대학교 의학전문대학원)
  • Published : 2009.04.30
Download PDF
⟨ Previous Next ⟩

Abstract

We previously demonstrated that zinc plus arachidonic acid (ZA) treatment lowered blood glucose levels in streptozotocin-induced diabetic rats, genetically diabetic obese (ob/ob) mice, and genetically diabetic, non-obese Goto-Kakizaki rats. However, plasma insulin levels did not increase with ZA treatment, suggesting that ZA lowers blood glucose levels not by stimulating pancreatic insulin secretion. However, it is unclear whether these agents lower blood glucose levels by decreasing hepatic glucose output (HGO) or by increasing glucose utilization in peripheral tissues, or both. In order to determine ZA target organ of insulin action, we divided 18 Sprague-Dawley rats weighing ${\sim}130g$ into 3 groups (6 rats per group) and treated them for four weeks with: (1) Control diet (regular rat chow), (2) High fructose (60.0%) diet only, and (3) the same fructose diet plus zinc (10 mg/L) and arachidonic acid (50 mg/L) containing drinking water. After 4 weeks, insulin action was assessed using the hyperinsulinemic euglycemic clamp technique. Food intake and body weights were comparable in all three groups of rats throughout the study period. Plasma glucose and insulin concentrations, glucose uptake, and HGO in the basal state were all the same in these three rat groups. During the clamp study, fructose-treated and fructose+ZA treated rat groups did not exhibit any detectable change on insulin-mediated glucose uptake compared to controls. High fructose feeding impaired insulin mediated suppression of HGO, compared to controls during clamp (4.39 vs. 2.35 mg/kg/min; p<0.05). However, ZA treatment in high fructose-fed rats showed a remarkable increase in hepatic insulin sensitivity compared to high fructose-fed rats, reflected by a complete recovery in suppression of HGO during the clamp (4.39 vs. 2.18 mg/kg/min; p<0.05). This data suggests that ZA increases insulin sensitivity in liver but not glucose utilization of peripheral tissues in high fructose-fed rats.

고 fructose 식이를 섭취시켜 제 2형 당뇨를 유발한 쥐에서 ZA의 섭취가 혈당 조절에 미치는 기전을 밝히고자 하였다. 4주 동안의 실험기간 중 Control군(normal chow diet), Fructose군(high-fructose diet)과 Fructose+ZA군(highfructose diet+ZA treatment) 간의 체중, 먹이 및 물의 섭취량에는 유의한 차이를 나타내지 않았다(p<0.05). 기저상태 (basal state)에서 혈장 포도당, 인슐린 농도 및 간의 포도당 생성률을 측정한 결과 Control군과 Fructose군 및 Fructose+ZA군 간의 차이를 나타내지 않았다. 인슐린 감수성을 알아보기 위한 hyperinsulinemic euglycemic clamp 실험에서 인슐린 농도와 포도당 농도는 군 간의 차이를 나타내지 않았다. 또한 인슐린 감수성 지표인 포도당 흡수(glucose uptake)에서도 역시 군 간의 차이를 발견하지 못하였다. 그러나 간의 인슐린 감수성 지표인 간의 포도당 생성률(HGO)에서는 Fructose군이 Control군에 비하여 유의적으로 증가되었고 (p<0.05), Fructose+ZA군이 대조군의 수준으로 감소되었다. 이것으로 미루어 볼 때 fructose 식이는 간에서 인슐린감수성을 감소시켰으나 당뇨는 유발되지 않았으며, ZA 섭취가 간의 포도당 생성률을 억제하는 것으로 보아 인슐린 감수성을 증가시키지만, 말초조직의 포도당 이용에는 영향을 미치지 않는 것으로 사료된다.

Keywords

References

  1. Kim YI, Choi CS, Kim SW, Kim HK, Kim CH, Park JY, Hong SK, Lee KU. 1998. Prevalence of Diabetes mellitus and impaired glucose tolerance in Korean adults living in Jungup district, South Korea. Diabetes. J Korean Diabetes Assoc 22: 363-371
  2. Ministry of Health & Welfare. 2006. (Illness of adults), The Third Korea National Health and Nutrition examination survey (KNHANESIII), 2005
  3. Warram JH, Martin BC, Krolewski AS, Soeldner JS, Kahn CR. 1990. Slow glucose removal rate and hyperinsulinemia precede the development of type II diabetes in the offspring of diabetic parents. Ann Intern Med 113: 909-915 https://doi.org/10.7326/0003-4819-113-12-909
  4. Lillioja S, Mott DM, Howard BV, Bennett PH, Yki-Jarvinen H, Freymond D, Nyomba BL, Zurlo F, Swinburn B, Bogardus C. 1988. Impaired glucose tolerance as a disorder of insulin action: longitudinal and crosssectional studies in Pima Indians. N Engl J Med 318: 1217-1225 https://doi.org/10.1056/NEJM198805123181901
  5. Bailey CJ. 1999. Insulin resistance and antidiabetic drugs. Biochem Pharmacol 55: 1511-1520 https://doi.org/10.1016/S0006-2952(99)00191-4
  6. Nazawa S, Cleveland T, Gaines PA, Chan P. 1998. Clinical risk associated with contrast angiography in metformin treated patients: a clinical review. Clin Radiol 53: 342-344 https://doi.org/10.1016/S0009-9260(98)80005-6
  7. Neuschwander-Tetri BA, Isley WL, Oki JC, Ramrakhiani S, Quiason SG, Phillips NJ, Brunt EM. 1998. Troglitazoninduced hepatic failure leading to liver transplantation. A case report. Ann Intern Med 129: 38-41 https://doi.org/10.7326/0003-4819-129-1-199807010-00009
  8. Gitlin N, Julie NL, Spurr CL, Lim KN, Juarbe HM. 1998. Two cases of severe clinical and histological hepatotoxicity associated with troglitazone. Ann Intern Med 129: 36-38 https://doi.org/10.7326/0003-4819-129-1-199807010-00008
  9. Song MK, Adham NF, Heng MC, Costea NV, Heng MK, Ament ME. 1995. Metabolic alterations of zinc and prostaglandins in both human and animal colonic tumor cells. J Am Coll Nutr 14: 473-479 https://doi.org/10.1080/07315724.1995.10718538
  10. Chausmer AB. 1998. Zinc, Insulin and diabetes. J Am Coll Nutr 17: 109-115 https://doi.org/10.1080/07315724.1998.10718735
  11. Tuvemo T, Ewald U, Kobbah M, Proos L. 1997. Serum magensium and protein concentrations during the first five year of insulin-depednet diabetes in children. Acta Pedaitr Suppl 418: 7-10
  12. Sleder J, Chen YD, Cully MD, Reaven GM. 1980. Hyperinsulinemia in fructose-induced hypertriglyceridemia in the rat. Metabolism 29: 303-305 https://doi.org/10.1016/0026-0495(80)90001-3
  13. Thorburn AW, Storlien LH, Jenkins AB, Khouri S, Kraegen EW. 1989. Fructose-induced in vivo insulin resistance and elevated plasma triglyceride levels in rats. Am J Clin Nutr 49: 1155-1163
  14. Pamies-Andreu E, Fiksen-Olsen M, Rizza RA, Romero JC. 1995. High-fructose feeding elicits insulin resistance without hypertension in normal mongrel dogs. Am J Hypertens 8: 732-738 https://doi.org/10.1016/0895-7061(95)00118-9
  15. Zavoroni I, Sander S, Scott S, Reaven GM. 1980. Effect of fructose feeding on insulin secretion and insulin action in the rat. Metabolism 29: 970-973 https://doi.org/10.1016/0026-0495(80)90041-4
  16. Storlien LH, Oakes ND, Pan DA, Kusonoki M, Jenkins AB. 1993. Syndromes of insulin resistance in the rat: inducement by diet and amelioration with benfluorex. Diabetes 42: 457-462 https://doi.org/10.2337/diabetes.42.3.457
  17. Kinlaw WB, Levine AS, Moreley JE, Silvis SE, McClain CJ. 1983. Abnormal zinc metabolism in type II diabetes mellitus. Am J Med 75: 273-277 https://doi.org/10.1016/0002-9343(83)91205-6
  18. Chooi MK, Todd JK, Boyd ND. 1976. Influence of age and sex on plasma zinc levels in normal and diabetic individuals. Nutr Metab 20: 135-142 https://doi.org/10.1159/000175697
  19. Halstead JA, Smith JC Jr, Irwin MI. 1974. A conspectus of research of zinc requirements of man. J Nutr 104: 345-349
  20. Arver S. 1982. Zinc and zinc ligands in human seminal plasma. III. the principal low molecular weight zinc ligand in prostatic secretion and seminal plasma. Acta Physiol Scand 116: 67-73 https://doi.org/10.1111/j.1748-1716.1982.tb10600.x
  21. Borkman M, Storlien LH, Pan DA, Jenkins AB, Chisholm DJ, Campbell LV. 1993. The relationship between insulin resistance and the fatty acid composition of phospholipids of skeletal muscle. N Engl J Med 328: 238-244 https://doi.org/10.1056/NEJM199301283280404
  22. Glasgow WC, Afshari CA, Barrett JC, Eling TE. 1992. Modulation of the epidermal growth factor mitogenic response by metabolites of linoleic and arachidonic acid in Syrian hamster embryo fibroblasts. Differential effects in tumor suppressor gene (+) and (-) phospholipid fatty acid composition in genetically lean (Fa/Fa) or obese (fa/fa) Zucker female phenotypes. J Biol Chem 267: 10771-10779
  23. Handler JA, Danilowicz RM, Eling TE. 1990. Mitogenic signaling by epidermal growth factor (EGF), but not platelet-derived growth factor, requires arachidonic acid metabolism in BALB/c 3T3 cells. Modulation of EGF-dependent c-myc expression by prostaglandins. J Biol Chem 265: 3669-3673
  24. Izawa T, Mochizuki T, Komabayashi Y, Suda K, Tsuboi M. 1994. Increase in cytosolic free Ca2+ in corticotropinstimulated white adipocytes. Am J Physiol 266: E418-426
  25. Landt M, Easom RA, Colca JR, Wolf BA, Turk J, Mills LA, McDaniel ML. 1992. Parallel effects of arachidonic acid on insulin secretion, calmodulin-dependent protein kinase activity and protein kinase C activity in pancreatic islets. Cell Calcium 13: 163-172 https://doi.org/10.1016/0143-4160(92)90044-S
  26. Satoh T, Cohen HT, Katz AI. 1992. Intracellular signaling in the regulation of renal Na-K-ATPase. I. Role of cyclic AMP and phospholipase A2. J Clin Invest 89: 1496-1500 https://doi.org/10.1172/JCI115740
  27. Song MK, Rosenthal MJ, Hong SJ, Harris DM, Hwang IK, Yip I, Golub MS, Ament ME, Go VL. 2001. Synergistic anti-diabetic activities of zinc, cyclo (his-pro) and arachidonic acid. Metabolism 50: 53-59 https://doi.org/10.1053/meta.2001.19427
  28. Miller GD, Keen CL, Stem JS, Uriu-Hare JY. 1998. Copper deficiency and arachidonic acid enhance insulin secretion in isolated pancreatic islets from lean (Fa/Fa) Zucker rats. Pancreas 17: 390-396 https://doi.org/10.1097/00006676-199811000-00010
  29. Aalusha PV, Caldwell A. 1983. Prostaglandins and diabetes mellitus. In Diabetes mellitus, theory and practice. 3rd ed. Ellenberg M, Rifkin H, eds. Medical Examination Publishing Co., New York, p 295-308
  30. Robertson RP. 1984. Prostaglandins, glucose homeostasis and diabetes mellitus. Med Clin North Am 65: 759-771
  31. Robertson RP, Chen M. 1977. A role for prostaglandin E in defective insulin secretion and carbohydrate intolerance in diabetes mellitus. J Clin Invest 60: 747-753 https://doi.org/10.1172/JCI108827
  32. Harrison HE, Reece AH, Johnson M. 1978. Decreased vascular prostacyclin in experimental diabetes. Life Sci 23: 351-356 https://doi.org/10.1016/0024-3205(78)90020-6
  33. Subbiah MTR, Deitemeyer D. 1980. Altered synthesis of prostaglandins in platelet and aorta from spontaneously diabetic Wistar rats. Biochem Med 23: 231-235 https://doi.org/10.1016/0006-2944(80)90076-9
  34. Johnson M, Harrison HE, Raftery AT, Elder HB. 1979. Vascular prostacyclin may be reduced in diabetes in man. Lancet I: 325-326 https://doi.org/10.1016/S0140-6736(79)90737-2
  35. Karageuzyan KG, Vartanyan GS, Agadjanov MI, Panossian AG, Hoult JR. 1998. Restoration of the disordered glucose-fatty acid cycle in alloxan-diabetic rats by trihydroxyoctadecadienoic acids from Bryonia alba, a native Armenian medicinal plant. Planta Med 64: 417-422 https://doi.org/10.1055/s-2006-957472
  36. Song MK, Mooradian AD. 1988. Intestinal zinc transport: Influence of streptozotocin-induced diabetes, insulin and arachidonic acid. Life Sci 42: 687-694 https://doi.org/10.1016/0024-3205(88)90460-2
  37. Rosenthal MJ, Hwang IK, Song MK. 2001. Effects of arachidonic acid and cyclo (his-pro) on zinc transport across small intestine and muscle tissues. Life Sci 70: 337-348 https://doi.org/10.1016/S0024-3205(01)01395-9
  38. Hwang IK, Go VL, Harris DM, Yip I, Song MK. 2002. Effects of arachidonic acid plus zinc on glucose disposal in genetically diabetic (ob/ob) mice. Diabetes Obes Metab 4: 124-131 https://doi.org/10.1046/j.1463-1326.2002.00195.x
  39. Song MK, Hwang IK, Rosenthal MJ, Harris DM, Yamaguchi DT, Yip I , Go VL. 2003. Antidiabetic actions of arachidonic acid and zinc in genetically diabetic Goto-Kakizaki rats. Metabolism 52: 7-12 https://doi.org/10.1053/meta.2003.50031
  40. Sharabi Y, Oron-Herman M, Kamari Y, Avni I, Peleg E, Shabtay Z, Grossman E, Shamiss A. 2007. Effect of PPARgamma agonist on adiponectin levels in the metabolic syndrome: lessons from the high fructose fed rat model. Am J Hypertens 20: 206-210 https://doi.org/10.1016/j.amjhyper.2006.08.002
  41. Bi XP, Tan HW, Xing SS, Wang ZH, Tang MX, Zhang Y, Zhang W. 2008. Overexpression of TRB3 gene in adipose tissue of rats with high fructose-induced metabolic syndrome. Endocr J 55: 747-752 https://doi.org/10.1507/endocrj.K08E-049
  42. Stanhope KL, Havel PJ. 2008. Endocrine and metabolic effects of consuming beverages sweetened with fructose, glucose, sucrose, or high-fructose corn syrup. Am J Clin Nutr 88: 1733S-1737S https://doi.org/10.3945/ajcn.2008.25825D
  43. Bray GA, Nielson SJ, Popkin BM. 2004. Consumption of high-fructose corn syrup in beverages may play a role in the epidemic of obesity. Am J Clin Nutr 79: 537-543
  44. Choi CS, Lee FN, Youn JH. 2001. Free fatty acids induce peripheral insulin resistance without increasing muscle hexosamine pathway product levels in rats. Diabetes 50: 418-424 https://doi.org/10.2337/diabetes.50.2.418
  45. Choi CS, Kim YB, Lee FN, Zabolotny JM, Kahn BB, Youn JH. 2002. Lactate induces insulin resistance in skeletal muscle by suppressing glycolysis and impairing insulin signaling. Am J Physiol Endocrinol Metab 283: E233-240 https://doi.org/10.1152/ajpendo.00557.2001
  46. Shulman GI. 2000. Cellular mechanisms of insulin resistance. J Clin Invest 106: 171-176 https://doi.org/10.1172/JCI10583
  47. Shulman GI. 2004. Unraveling the cellular mechanism of insulin resistance in humans: new insights from magnetic resonance spectroscopy. Physiology (Bethesda) 19: 183-190 https://doi.org/10.1152/physiol.00007.2004
  48. Petersen KF, Shulman GI. 2006. New insights into the pathogenesis of insulin resistance in humans using magnetic resonance spectroscopy. Obesity (SilverSpring) 14: 34S-40S https://doi.org/10.1038/oby.2006.280
  49. Summers SA, Nelson DH. 2005. A role for sphingolipids in producing the common features of type 2 diabetes, metabolic syndrome X, and Cushing's syndrome. Diabetes 54: 591-602 https://doi.org/10.2337/diabetes.54.3.591
  50. Lowell BB, Shulman GI. 2005. Mitochondrial dysfunction and type 2 diabetes. Science 307: 384-387 https://doi.org/10.1126/science.1104343
  51. Randle PJ, Garland PB, Hales CN, Newsholme EA. 1963. The glucose fatty-acid cycle its role in insulin sensitivity and the metabolic disturbances of diabetes mellitus. Lancet 1(7285): 785-789 https://doi.org/10.1016/S0140-6736(63)91500-9
  52. Randle PJ, Kerbey AL, Espinal J. 1988. Mechanisms decreasing glucose oxidation in diabetes and starvation: role of lipid fuels and hormones. Diabetes Metab Rev 4: 623-638
  53. Randle PJ, Priestman DA, Mistry S, Halsall A. 1994. Mechanisms modifying glucose in diabetes mellitus. Diabetologia 37(suppl 2): s155-s161 https://doi.org/10.1007/BF00400839
  54. Marshall S, Bacote V, Traxinger RR. 1991. Discovery of a metabolic pathway mediating glucose-induced desensitization of the glucose transport system: role of hexosamine biosynthesis in the induction of insulin resistance. J Biol Chem 266: 4706-4712
  55. Rossetti L, Hawkins M , Chen W , Gindi J, Barzilai N. 1995. In vivo glucosamine infusion induces insulin resistance in normoglycemic but not in hyperglycemic conscious rats. J Clin Invest 96: 132-140 https://doi.org/10.1172/JCI118013
  56. Choi CS, Fillmore JJ, Kim JK, Liu ZX, Kim S, Collier EF, Kulkarni A, Distefano A, Hwang YJ, Kahn M, Chen Y, Yu C, Moore IK, Reznick RM, Higashimori T, Shulman GI. 2007. Overexpression of uncoupling protein 3 in skeletal muscle protects against fat-induced insulin resistance. J Clin Invest 117: 1995-2003 https://doi.org/10.1172/JCI13579
  57. Choi CS, Savage DB, Abu-Elheiga L, Liu ZX, Kim S, Kulkarni A, Distefano A, Hwang YJ, Reznick RM, Codella R, Zhang D, Cline GW, Wakil SJ, Shulman GI. 2007. Continuous fat oxidation in acetyl-CoA carboxylase 2 mutant mice increases total energy expenditure, reduces fat mass, and improves insulin sensitivity. Proc Natl Acad Sci USA 104: 16480-16485 https://doi.org/10.1073/pnas.0706794104
  58. Hajduch E, Balendran A, Batty IH, Litherland GJ, Blair AS, Downes CP, Hundal HS. 2001. Ceramide impairs the insulin-dependent membrane recruitment of protein kinase B leading to a loss in downstream signaling in L6 skeletal muscle cells. Diabetologia 44: 173-183 https://doi.org/10.1007/s001250051596
  59. Dai S, McNeill JH. 1992. Effects of fructose loading in streptozotocin-diabetic and nindiabetic rats. Can J Physiol Pharmacol 70: 1583-1589 https://doi.org/10.1139/y92-227
  60. Hwang IS, Ho H, Hoffman BB, Reaven GM. 1987. Fructose-induced insulin resistance and hypertension in rats. Hypertension 10: 512-516 https://doi.org/10.1161/01.HYP.10.5.512
  61. Lee MK, Miles PDG, Khoursheed M, Gao KM, Moossa AR, Olefsky JM. 1994. Metabolic effects of troglitazone on fructose-induced insulin resistance in the rat. Diabetes 43: 1435-1439 https://doi.org/10.2337/diabetes.43.12.1435
  62. Stark AH, Timar B, Madar Z. 2000. Adaptation of Sprague Dawley rats to long-term feeding of high fat or high fructose diets. Eur J Nutr 39: 229-234 https://doi.org/10.1007/s003940070016
  63. Ishida T. 2000. Insulin resistance and liver. Nippon Rinsho 58: 348-356
  64. Koivisto VA, Yki-Jarvinen H. 1993. Fructose and insulin sensitivity in patients with type 2 diabetes. J Intern Med 233: 145-153 https://doi.org/10.1111/j.1365-2796.1993.tb00667.x
  65. Thorburn AW, Crapo PA, Griver K, Wallace P, Henry RR. 1990. Long-term effects of dietary fructose on carbohydrate metabolism in NIDDM. Metabolism 39: 58-63 https://doi.org/10.1016/0026-0495(90)90148-6
  66. Tobey TA, Mondon CE, Zavaroni I, Reaven GM. 1982. Mechanism of insulin resistance in fructose-fed rats. Metabolism 31: 608-612 https://doi.org/10.1016/0026-0495(82)90100-7
  67. Ikeda T, Fujiyama K. 1998. The effect of pioglitazone on glucose metabolism and insulin uptake in the perfused liver and hindquarter of high-fructose-fed rats. Metabolism 47: 1152-1155 https://doi.org/10.1016/S0026-0495(98)90292-X

Cited by

  1. The Effect of Lotus (Nelumbo nucifera) Leaf, Stem, and Yeonjabang Powder Extract on the Biochemical Factors in Serum in Mice Fed a High-Fat Diet vol.29, pp.5, 2016, https://doi.org/10.9799/ksfan.2016.29.5.684
  2. AMPK 활성화를 통한 목통의 항산화 효과 vol.29, pp.1, 2015, https://doi.org/10.15188/kjopp.2015.02.29.1.18